BELLEROPHON THERAP.DL-,01 WKN: A14R8L ISIN: US0787711029 Kürzel: 6L7 Forum: Aktien Thema: Hauptdiskussion

https://seekingalpha.com/article/4206639-bellerophon-therapeutics-inopulse-gets-shot-redemption

Bellerophon Therapeutics: INOpulse Gets A Shot At Redemption Summary The company recently lost around two-thirds of its value when the phase 3 INOvation-1 study in PAH was stopped early for futility. Institutional positioning and recent accumulation suggests the story is far from over. Indications of high unmet medical need representing blockbuster opportunities are being targeted. By year end data from the phase 2 PH-ILD study is expected. Prior data plus known benefits of chronic iNO treatment are suggestive of a positive result. Significant risks should be considered, including dilution in the near term, disappointing data and the fact that pivotal studies still need to be conducted.

Wl

eskaliert!

Ja ich finde sie auch sehr interessant✌

Olli bist du investiert?